title: Epirubicin-induced differentiation of human neuroblastoma cells in vitro.
abstract: On the basis that inhibition of cell proliferation may play a role in the differentiation process, we have studied the effect of the antineoplastic drug epirubicin, an antibiotic of the anthracycline group, on human neuroblastoma cell lines SK-N-MC, SK-N-SH, SJ-N-KP, TS12 and AF8. Epirubicin induced morphological and biochemical differentiation in these cultured cell lines; treatment with it stimulated the outgrowth of neurites and increased acetylcholinesterase activity.
authors.forename: P
authors.initials: P
authors.lastname: Rocchi
authors.forename: A M
authors.initials: AM
authors.lastname: Ferreri
authors.forename: G
authors.initials: G
authors.lastname: Simone
authors.forename: G
authors.initials: G
authors.lastname: Prodi
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004317:Doxorubicin / Q000494:pharmacology*; D015251:Epirubicin; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009447:Neuroblastoma / Q000473:pathology*; D013997:Time Factors
chemical_list: D006131:Growth Inhibitors; D015251:Epirubicin; D004317:Doxorubicin; D000110:Acetylcholinesterase